Scholarlink

Background <p>To evaluate achievement of Japanese guideline-concordant treatment (J-GCT) and examine its association with clinical outcomes among older patients with endometrial cancer.</p> Methods <p>We retrospectively reviewed 130 patients aged ≥ 70&#xa0;years diagnosed between 2010 and 2019. J-GCT was defined as receipt of primary surgery, standard surgical staging including lymph node assessment when indicated, and risk-adapted adjuvant chemotherapy. Progression-free survival (PFS) and overall survival (OS) were analyzed using Kaplan–Meier methods and log-rank tests. Multivariable Cox models evaluated factors associated with PFS.</p> Results <p>J-GCT achievement was significantly lower in patients aged ≥ 75&#xa0;years than in those aged 70–74&#xa0;years (28.1% vs. 71.2%, <i>P</i> &lt; 0.001). Patients aged ≥ 75&#xa0;years less frequently underwent primary surgery (84.2% vs 97.3%, <i>P</i> = 0.011) and lymph node assessment (45.8% vs 80.3%, <i>P</i> &lt; 0.001). Adjuvant chemotherapy for intermediate- or high-risk disease was less frequently administered in patients aged ≥ 75&#xa0;years (38.7% vs 86.4%, <i>P</i> &lt; 0.001). Perioperative complications were infrequent, and no treatment-related deaths were observed. J-GCT achievement was associated with improved PFS (<i>P</i> &lt; 0.001) and OS (<i>P</i> = 0.004). In multivariable analysis adjusting for age and selected clinicopathologic factors, failure to achieve J-GCT remained associated with inferior PFS (adjusted hazard ratio 3.20, 95% confidence interval 1.43–7.15; <i>P</i> = 0.005).</p> Conclusion <p>J-GCT achievement was lower among patients aged ≥ 75&#xa0;years, particularly with respect to lymph node assessment and risk-adapted adjuvant chemotherapy. Failure to achieve J-GCT was associated with inferior PFS after adjustment, although this group included heterogeneous treatment patterns with potentially different prognostic implications. These findings support treatment decision-making based on structured clinical evaluation rather than chronological age alone.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Guideline-concordant treatment and clinical outcomes in older patients with endometrial cancer in Japan: a retrospective single-institution study

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年7月23日

查看全文
  • Kanako Kasuya,
  • Naoko Komura,
  • Satoshi Nakagawa,
  • Tsuyoshi Takiuchi,
  • Eiji Kobayashi,
  • Kae Hashimoto,
  • Yutaka Ueda,
  • Kenjiro Sawada,
  • Michiko Kodama

摘要

Background

To evaluate achievement of Japanese guideline-concordant treatment (J-GCT) and examine its association with clinical outcomes among older patients with endometrial cancer.

Methods

We retrospectively reviewed 130 patients aged ≥ 70 years diagnosed between 2010 and 2019. J-GCT was defined as receipt of primary surgery, standard surgical staging including lymph node assessment when indicated, and risk-adapted adjuvant chemotherapy. Progression-free survival (PFS) and overall survival (OS) were analyzed using Kaplan–Meier methods and log-rank tests. Multivariable Cox models evaluated factors associated with PFS.

Results

J-GCT achievement was significantly lower in patients aged ≥ 75 years than in those aged 70–74 years (28.1% vs. 71.2%, P < 0.001). Patients aged ≥ 75 years less frequently underwent primary surgery (84.2% vs 97.3%, P = 0.011) and lymph node assessment (45.8% vs 80.3%, P < 0.001). Adjuvant chemotherapy for intermediate- or high-risk disease was less frequently administered in patients aged ≥ 75 years (38.7% vs 86.4%, P < 0.001). Perioperative complications were infrequent, and no treatment-related deaths were observed. J-GCT achievement was associated with improved PFS (P < 0.001) and OS (P = 0.004). In multivariable analysis adjusting for age and selected clinicopathologic factors, failure to achieve J-GCT remained associated with inferior PFS (adjusted hazard ratio 3.20, 95% confidence interval 1.43–7.15; P = 0.005).

Conclusion

J-GCT achievement was lower among patients aged ≥ 75 years, particularly with respect to lymph node assessment and risk-adapted adjuvant chemotherapy. Failure to achieve J-GCT was associated with inferior PFS after adjustment, although this group included heterogeneous treatment patterns with potentially different prognostic implications. These findings support treatment decision-making based on structured clinical evaluation rather than chronological age alone.